People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other Health Care, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Discover Echo Inc. | — | Other Health Care | Series A | $18.6M | $80.7M | 2017 |
| Eclipse Bioinnovations, Inc. | — | Biotechnology | Series A | $16.9M | $13.4M | 2021 |
| Eclipse Therapeutics, Inc. | — | Other | Seed | $2.8M | $51.6M | 2011 |
Peter Chu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Chu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Huber | 1 | 75 |
| Jonathan Lim | 1 | 9 |
| Andrew Krowne | 1 | 5 |
| Dirk Soenksen | 1 | 3 |
| Christopher Reyes | 1 | 3 |
| Dean Rosenberg | 1 | 3 |
| Eugene Yeo | 1 | 2 |
| Eugene Cho | 1 | 1 |
| Daniel Vasella | 1 | 1 |
| Edmond Wong | 1 | 1 |
| Daniel L Vasella | 1 | 1 |
| Eric L Van Nostrand | 1 | 1 |
| Hallie L Kuhn | 1 | 1 |
| Eugene W Yeo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.